HomeEGRX • OTCMKTS
add
Eagle Pharmaceuticals Inc
Previous close
$0.65
Day range
$0.65 - $0.65
Year range
$0.0025 - $6.81
Market cap
8.44M USD
Avg Volume
18.30K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2023info | Y/Y change |
|---|---|---|
Revenue | 64.65M | — |
Operating expense | 37.48M | — |
Net income | 5.16M | — |
Net profit margin | 7.99 | — |
Earnings per share | 1.18 | -24.36% |
EBITDA | 15.88M | — |
Effective tax rate | 44.46% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.35M | — |
Total assets | 404.82M | — |
Total liabilities | 152.78M | — |
Total equity | 252.04M | — |
Shares outstanding | 12.99M | — |
Price to book | 0.03 | — |
Return on assets | 6.29% | — |
Return on capital | 7.97% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2023info | Y/Y change |
|---|---|---|
Net income | 5.16M | — |
Cash from operations | -126.00K | — |
Cash from investing | -6.00K | — |
Cash from financing | -6.41M | — |
Net change in cash | -6.54M | — |
Free cash flow | 2.62M | — |
About
Founded
2007
Headquarters
Website
Employees
134
